Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

KOSDAQ/338840 stock hub

KOSDAQ/338840 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/338840is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

321.8B

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/338840

In the news

Latest news · KOSDAQ/338840

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-181.8

P25 n/aP50 n/aP75 n/a

ROIC-18.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/338840 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

154

Groups with data

Currency

KRW

Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Enterprise value	KRW 292.3B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	KRW 321.8B
Price	KRW 21,200
Price currency	KRW
Sic	2836
Symbol	kosdaq/338840
Website	https://www.ybiologics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.06%
EV Earnings	-6.95x
EV/FCF	-42.57x
EV/Sales	100.33x
FCF yield	-2.13%
P/B ratio	12.1x
P/S ratio	110.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBITDA Margin	-251.87%
Gross margin	78.75%
Gross Profit	KRW 2.3B
Gross Profit Growth	-46.24%
Gross Profit Growth Q	-50.08%
Gross Profit Growth3 Y	22.26%
Net Income	KRW -42B
Pretax Margin	-1,442.67%
ROA	-14.95
Roa5y	-23.2
ROCE	-16.99
ROE	-181.8
Roe5y	-86.62
ROIC	-18.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	175.52%
Revenue Growth	-49.45x
Revenue Growth Q	-60.9x
Revenue Growth3 Y	-11.13x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.08
Assets	KRW 55.8B
Cash	KRW 44.3B
Current Assets	KRW 44.8B
Current Liabilities	KRW 1.2B
Debt	KRW 14.8B
Debt Equity	KRW 0.55
Debt FCF	KRW -2.15
Equity	KRW 26.6B
Interest Coverage	-7.36
Liabilities	KRW 29.2B
Long Term Assets	KRW 11B
Long Term Liabilities	KRW 28B
Net Cash	KRW 29.5B
Net Cash By Market Cap	KRW 9.17
Net Cash Growth	158.35%
Net Debt Equity	KRW -1.11
Tangible Book Value	KRW 26.1B
Tangible Book Value Per Share	KRW 1,740
WACC	4.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	36.16
Net Working Capital	KRW -447.4M
Quick ratio	35.93
Working Capital	KRW 43.6B
Working Capital Turnover	KRW 0.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.79%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	175.33%
200-day SMA	20,939.6
50-day SMA	26,730
50-day SMA vs 200-day SMA	50over200
All Time High	38,000
All Time High Change	-44.21%
All Time High Date	2026-03-19
All Time Low	5,330
All Time Low Change	297.75%
All Time Low Date	2025-04-07
ATR	1,968.2
Beta	0.12
Beta1y	-0.09
Beta2y	0.23
Ch YTD	-7.42
High	21,950
High52	38,000
High52 Date	2026-03-19
High52ch	-44.21%
Low	20,950
Low52	7,370
Low52 Date	2025-05-09
Low52ch	187.65%
Ma50ch	-20.69%
Price vs 200-day SMA	1.24%
RSI	35.36
RSI Monthly	55.1
RSI Weekly	45.08
Sharpe ratio	1.55x
Sortino ratio	2.53
Total Return	-0.79%
Tr YTD	-7.42
Tr1m	-11.85%
Tr1w	-2.3%
Tr3m	-7.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -9.3B
Operating margin	-318.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,634,794%
Net Borrowing	34,326,151,340
Shares Insiders	29.47%
Shares Institutions	3.32%
Shares Out	15,178,081
Shares Qo Q	0.11%
Shares Yo Y	0.79%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -7.5B
Average Volume	205,860.4x
Bv Per Share	1,775.2
CAPEX	KRW -1B
Ch1m	-11.85
Ch1w	-2.3
Ch1y	175.3
Ch3m	-7.02
Ch6m	2.91
Change	0%
Change From Open	0.24
Close	21,200
Days Gap	-0.24
Depreciation Amortization	1,932,159,000
Dollar Volume	2,692,569,600
EBIT	KRW -9.3B
EBITDA	KRW -7.3B
EPS	KRW -2,822
F Score	3
FCF	KRW -6.9B
FCF EV Yield	-2.35x
FCF Per Share	KRW -452
Financing CF	37,763,392,570
Fiscal Year End	December
Founded	2,007
Investing CF	-2,084,407,120
Is Primary Listing	1
Last Report Date	2025-12-31
Ma150	23,921.5
Ma150ch	-11.38%
Ma20	23,830
Ma20ch	-11.04%
Net CF	29,838,973,980
Open	21,150
Position In Range	25
Ppne	6,898,861,120
Price Date	2026-05-08
Ptbv Ratio	12.34
Relative Volume	0.62x
Revenue	2,912,981,880x
SBC By Revenue	20.18x
Share Based Comp	587,819,000
Tr6m	2.91%
Volume	127,008
Z Score	0.2

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KOSDAQ/338840 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/338840 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/338840?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.3%

Share of float held by funds and institutions

Insider ownership

+29.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.8%

Negative means the company is buying back shares.

Technical

KOSDAQ/338840 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

35.4

Neutral momentum band

Price vs 200-day MA

+1.2%

50/200-day relationship not available

Beta (5Y)

0.12

Less volatile than the market

Sharpe ratio

1.55

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/338840

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/338840 stock rating?

kosdaq/338840 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/338840 analysis?

The full report lives at /stocks/kosdaq/338840/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/338840?

The latest report frames kosdaq/338840 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/338840 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.